VanEck Vectors Coal ETF
Limited financial coverage for KOL.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Range $60 – $60
Price Chart
About the company
The VanEck Vectors Coal ETF (KOL) is designed to closely mirror, before accounting for fees and expenses, the total return performance (both price appreciation and income generation) of the MVIS® Global Coal Index. To achieve this objective, the fund typically commits at least 80% of its overall assets to the component securities that constitute its benchmark index. The MVIS® Global Coal Index encompasses companies operating within the global coal sector that generate a minimum of 50% of their income from various coal-related operations.
- IPO
- 2008
Get TickerSpark's AI analysis on KOL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $35.33M
- Div Yield
- 3.42%
- 52W High
- $99.33
- 52W Low
- $54.10
- 50D MA
- $94.92
- 200D MA
- $81.72
- Beta
- 1.18
- Avg Volume
- 8.23K
No earnings-call transcripts are available for KOL yet.
- Free Float
- 0.0%
- Shares Outstanding
- 372.25K
- Float Shares
- 0
Our KOL coverage
Recent articles, reports, and earnings notes.
No research on KOL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KOL report →Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald
globenewswire.com · Aug 18
Dogwood to Host Virtual KOL Event to Discuss Halneuron® for the Treatment of Chemotherapy Induced Neuropathic Pain on September 1, 2026
globenewswire.com · Aug 17
Tvardi Therapeutics to Host KOL Webinar on the Clinical Potential of TTI-109 in Ulcerative Colitis (UC) and the Evolving Treatment Landscape, on August 19, 2026
globenewswire.com · Aug 12
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
globenewswire.com · Aug 11
NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS"
prnewswire.com · Jul 6
OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026
globenewswire.com · Jul 2
Cantargia and H.C. Wainwright to Host KOL Call on The Case for Nadunolimab in PDAC
accessnewswire.com · Jun 11
TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer
gurufocus.com · Jun 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.